touchLearning Activities
Education, Conference Coverage and Articles
In this interview at EASD 2026, Katherine Tuttle discusses ACHIEVE-4 findings on the potential kidney-protective effects of orforglipron in people with type 2 diabetes and high cardiovascular risk, and the need for dedicated trials to confirm its long-term renal benefits.
In this EASD 2026 interview, Viral Shah discusses how continuous glucose monitoring could support earlier diabetes diagnosis, improve risk prediction and enable more personalized treatment and monitoring.
In this interview, Pablo Mora discusses phase 2b findings for zenagamtide (amycretin), a novel unimolecular GLP-1 and amylin receptor agonist, including its effects on glycemic control and body weight in people with type 2 diabetes, and the potential of ongoing phase 3 trials.
New findings presented at EASD 2026 suggest that mild, lifelong reductions in insulin signaling may be associated with a more favorable metabolic profile, challenging the view that all forms of insulin resistance are detrimental to health.
From the relationship between glucose control and quality of life to the benefits of exercise and an unexpected finding on COVID-19 and type 1 diabetes, we highlight three studies presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 in Milan.
Updated guidance presented at EASD 2026 emphasizes earlier use of organ-protective therapies, individualized weight management, and a broader approach to preventing diabetes-related complications.
Experts at EASD 2026 have welcomed a new European initiative encouraging routine health checks to identify cardiovascular and metabolic risk factors before complications develop.
EASD President Francesco Giorgino previews EASD 2026, discussing the key developments set to shape diabetes research and care, including incretin therapies, type 1 diabetes, AI and diabetes technology, personalized care, screening, and his priorities for EASD during his presidency.
Meet the endocrinologists shaping the future of the specialty. The touchENDOCRINOLOGY Future Leaders 2026 are rising stars nominated by the endocrinology community for their contributions to research, clinical practice and innovation. Discover the clinicians and researchers challenging convention, advancing care and driving progress across endocrinology.
Dr Maria Martinez-Cruz is a physician-scientist and touchENDOCRINOLOGY Future Leader 2026. In this interview, she discusses cardiometabolic research, the mentors who shaped her career, balancing clinical practice and research, and her vision for inspiring the next generation of physician-scientists.
Dr Rossella Cannarella discusses her journey in endocrinology, the role of mentorship, and her research in male infertility, reproductive endocrinology and sperm epigenetics, sharing advice for future generations.
We are delighted to announce Dr Stefano Passanisi as a touchENDOCRINOLOGY Future Leader 2026, recognized by peers as an emerging leader in pediatric endocrinology. Dr Stefano Passanisi is a pediatrician and clinical researcher at the University Hospital of Messina, Italy. Working ...
Dr Stéfanie Parisien-La Salle discusses her path into endocrinology, the mentors who shaped her career, her passion for adrenal research, and how research continues to inform patient care.
In this touchENDOCRINOLOGY Future Leaders 2026 Q&A, Dr Simon Berry (Sheffield, UK) reflects on the experiences that led him into diabetes and endocrinology, the mentors who have influenced his clinical and academic journey, and the innovations he believes are set to transform patient care. From advances in immunotherapy and islet transplantation to the evolving landscape of diabetes treatment, Simon shares his perspectives on the opportunities ahead for the specialty.
We are delighted to announce Dr Rimesh Pal as a touchENDOCRINOLOGY Future Leader 2026, recognized by his peers as an emerging leader in endocrinology and metabolic bone research. Dr Rimesh Pal is Associate Professor of Endocrinology at the Postgraduate Institute of ...
In this touchENDOCRINOLOGY Future Leader 2026 Q&A, Dr Qilin Zhang reflects on the experiences that have shaped his career across endocrinology, neurosurgery, and translational research. He discusses collaboration, balancing clinical and academic priorities, and how precision approaches are helping redefine the future of pituitary tumor management.
Dr Mindy Lee discusses mentorship, patient-centred care and the potential of diabetes technology to improve outcomes, sharing how clinical experiences inspire innovative, equitable solutions for children and young people.
touchENDOCRINOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
